Results 181 to 190 of about 45,635 (259)
Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
, 2020 María Rosario Capeding, Edison Alberto, Jodi Feser, Jessica Mooney, Yuxiao Tang, Susette Audet, Judy A. Beeler, Damon W. Ellison, Lei Zhang, G. William Letson, Kathleen M. Neuzil, Anthony A. Marfin +11 moreopenalex +1 more sourceSafety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study
Jagannatha R Pula, Pradeep K, Rakeshkumar M Patel, Sanjay V Mankar, Sapan Vinayak, Santanu Ray, Sabyasachi Bhattacharjee, Piyush Jain, Poonam Bhatia, Trayambak Dutta, Manish Mahajan +10 moreopenalex +1 more sourceEpstein–Barr Virus, but Not Cytomegalovirus, Latency Accelerates the Decay of Childhood Measles and Rubella Vaccine Responses—A 10-Year Follow-up of a Swedish Birth Cohort
, 2017 Gintare Lasaviciute, Sophia Björkander, Claudia Carvalho‐Queiroz, Ida Hed Myrberg, Bianca Nussbaum, Caroline Nilsson, Mats Bemark, Anna Nilsson, Eva Sverremark‐Ekström, Shanie Saghafian‐Hedengren +9 moreopenalex +1 more sourceA measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial. [PDF]
LancetAdigweme I, Yisa M, Ooko M, Akpalu E, Bruce A, Donkor S, Jarju LB, Danso B, Mendy A, Jeffries D, Segonds-Pichon A, Njie A, Crooke S, El-Badry E, Johnstone H, Royals M, Goodson JL, Prausnitz MR, McAllister DV, Rota PA, Henry S, Clarke E. +21 moreeuropepmc +1 more source